World's Best Scientists 2026 revealed!
Award Badge
Immunology
Iran
2026
Award Badge
Medicine
Iran
2026

D-Index & Metrics

Immunology

D-Index
108
Citations
66447
World Ranking
528
National Ranking
1

Medicine

D-Index
111
Citations
87673
World Ranking
5221
National Ranking
7

Nima Rezaei publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nima Rezaei sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 1,199 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nima Rezaei D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nima Rezaei sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 108 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Iran Leader Award
  • 2026 - Research.com Medicine in Iran Leader Award
  • 2025 - Research.com Immunology in Iran Leader Award
  • 2025 - Research.com Medicine in Iran Leader Award
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Nima Rezaei is affiliated with Tehran University of Medical Sciences in Iran. Their work encompasses extensive research in medicine, with a particular focus on biochemistry, genetics, and molecular biology.

The scientist's recent publications address critical topics related to COVID-19 and immunology. Notable recent papers include:

  • COVID-19: Transmission, prevention, and potential therapeutic opportunities (2020, Clinica Chimica Acta)
  • Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes (2021, International Immunopharmacology)
  • COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being (2020, Journal of Clinical Virology)
  • Role of Toll-like receptors in the pathogenesis of COVID-19 (2021, Journal of Medical Virology)
  • Lymphopenia in COVID-19: Therapeutic opportunities (2020, Cell Biology International)

The scope of their research spans several subfields, particularly immunology, infectious diseases, molecular biology, oncology, and genetics. Their studies cover key topics such as:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Immunodeficiency and Autoimmune Disorders
  • Immune Cell Function and Interaction
  • Long-Term Effects of COVID-19
  • Blood disorders and treatments
  • Cancer Immunotherapy and Biomarkers

Nima Rezaei has collaborated frequently with several researchers, including Amene Saghazadeh, Hassan Abolhassani, Niloufar Yazdanpanah, Sepideh Razi, and Sara Hanaei. These collaborations reflect a sustained engagement with peers in related fields.

Their work has been published repeatedly in several distinguished venues. Key publication venues include:

  • Advances in Experimental Medicine and Biology
  • Reviews in the Neurosciences
  • International Immunopharmacology
  • Expert Review of Clinical Immunology
  • Journal of Clinical Immunology

In addition to journal articles, the scientist has contributed to numerous book publications. Notable publishers include Springer Nature, Springer International Publishing, and IntechOpen. Important book titles include:

  • Coronavirus Disease - COVID-19 (Springer Nature, 2021)
  • Frontotemporal Dementias (Springer Nature, 2021)
  • Multifaceted Biomedical Applications of Graphene (Springer Nature, 2022)
  • Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1 (Springer Nature, 2023)
  • Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2 (Springer Nature, 2023)
  • The Immunogenetics of Dermatologic Diseases (Springer Nature, 2022)
  • Transdisciplinarity (Springer International Publishing, 2022)
  • Tuberculosis (Springer International Publishing, 2023)
  • Brain, Decision Making and Mental Health (Springer International Publishing, 2023)
  • Pneumonia (IntechOpen, 2021)

The scientist has been recognized as a member of the European Academy of Sciences and Arts.

Best Publications

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Theo Vos;Theo Vos;Theo Vos;Stephen S. Lim;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati;Kaja M. Abbas;Kaja M. Abbas;Kaja M. Abbas

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Christopher J.L. Murray;Christopher J.L. Murray;Christopher J.L. Murray;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Peng Zheng;Peng Zheng;Peng Zheng;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati

  • Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017

    Christina Fitzmaurice;Degu Abate;Naghmeh Abbasi;Hedayat Abbastabar

  • The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Sudabeh Alatab;Sadaf G Sepanlou;Kevin Ikuta;Homayoon Vahedi

  • Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

    Haidong Wang;Kaja M. Abbas;Mitra Abbasifard;Mohsen Abbasi-Kangevari

  • COVID-19: Transmission, prevention, and potential therapeutic opportunities.

    Melika Lotfi;Michael R. Hamblin;Nima Rezaei;Nima Rezaei

  • A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections

    Erik-Oliver Glocker;Andre Hennigs;Mohammad Nabavi;Alejandro A. Schäffer

  • Five insights from the Global Burden of Disease Study 2019

    Christopher J.L. Murray;Cristiana Abbafati;Kaja M. Abbas;Mohammad Abbasi

  • The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Farin Kamangar;Dariush Nasrollahzadeh;Saeid Safiri;Sadaf G Sepanlou

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019.

    Rafael Lozano;Nancy Fullman;John Everett Mumford;Megan Knight

  • The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017

    Arash Etemadi;Saeid Safiri;Sadaf G Sepanlou;Kevin Ikuta

  • Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity

    Gabriela Lopez-Herrera;Giacomo Tampella;Qiang Pan-Hammarström;Peer Herholz

  • HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)

    Christoph Klein;Magda Grudzien;Giridharan Appaswamy;Manuela Germeshausen

  • A systematic review on CO2 capture with ionic liquids: Current status and future prospects

    Mahsa Aghaie;Nima Rezaei;Sohrab Zendehboudi

  • Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes

    Maedeh Arabpour;Amene Saghazadeh;Nima Rezaei

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.

    Katherine R Paulson;Aruna M Kamath;Tahiya Alam;Kelly Bienhoff

  • COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being.

    Bobak Moazzami;Niloofar Razavi-Khorasani;Arash Dooghaie Moghadam;Ermia Farokhi

  • Superhydrophobic and superoleophilic membranes for oil-water separation application: A comprehensive review

    Seyedabbas Rasouli;Nima Rezaei;Hamideh Hamedi;Sohrab Zendehboudi

  • The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017

    Lisa M. Force;Ibrahim Abdollahpour;Shailesh M Advani;Dominic Agius

  • A Syndrome with Congenital Neutropenia and Mutations in G6PC3

    Kaan Boztug;Giridharan Appaswamy;Angel Ashikov;Alejandro A. Schäffer

  • Applications of hybrid models in chemical, petroleum, and energy systems: A systematic review

    Sohrab Zendehboudi;Nima Rezaei;Ali Lohi

  • Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency

    Vanessa Sancho-Shimizu;Rebeca Pérez de Diego;Lazaro Lorenzo;Rabih Halwani

  • The phenotype of human STK4 deficiency

    Hengameh Abdollahpour;Giridharan Appaswamy;Daniel Kotlarz;Daniel Kotlarz;Jana Diestelhorst;Jana Diestelhorst

  • DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients

    Susanne E. Aydin;Sara Sebnem Kilic;Caner Aytekin;Ashish Kumar

  • Lymphopenia in COVID-19: Therapeutic opportunities.

    Nazanin Fathi;Nazanin Fathi;Nima Rezaei;Nima Rezaei

  • Role of Toll-like receptors in the pathogenesis of COVID-19.

    Shaghayegh Khanmohammadi;Shaghayegh Khanmohammadi;Nima Rezaei;Nima Rezaei

Frequent Co-Authors

Asghar Aghamohammadi
Asghar Aghamohammadi Tehran University of Medical Sciences
Gholamreza Azizi
Gholamreza Azizi Alborz University of Medical Sciences
Lennart Hammarström
Lennart Hammarström Karolinska Institute
Hans D. Ochs
Hans D. Ochs University of Washington
Michael R. Hamblin
Michael R. Hamblin University of Johannesburg
Sohrab Zendehboudi
Sohrab Zendehboudi Memorial University of Newfoundland
Ali H. Mokdad
Ali H. Mokdad University of Washington
Morteza Mahmoudi
Morteza Mahmoudi Michigan State University
Florian Fischer
Florian Fischer Charité - University Medicine Berlin
Abbas Mirshafiey
Abbas Mirshafiey Tehran University of Medical Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often leads to interdisciplinary opportunities in healthcare, especially in nursing and advanced practice roles. For those interested in specializing in psychiatric care, exploring online pmhnp programs with clinical placement can provide valuable hands-on experience essential for effective patient care.

Cost is a significant consideration when choosing a program. Many students seek cheap psych np programs to balance quality education with financial responsibility. These programs often maintain strong reputations while offering more accessible tuition rates.

Career advancement within nursing often involves earning a Doctor of Nursing Practice (DNP) degree, which can lead to higher salaries. Understanding the dnp salary landscape by state helps prospective students make informed decisions on where to study and practice.

Additionally, many nurses look to broaden their clinical expertise by transitioning from family nurse practitioner roles to specialized areas. Learning how to fnp to acute care certification is an increasingly common pathway for those focused on critical and acute patient care within immunology and related fields.

Best Scientists Citing Nima Rezaei

Trending Scientists

Recently Published Articles